Conference Coverage

Pediatric Myasthenia Gravis: Don’t Treat Children Like Adults


 

FROM AANEM 2024

Don’t Neglect Supportive Care

Ginsberg urged colleagues to consider supportive care measures. Advocacy groups such as the Myasthenia Gravis Foundation of America can help with weight management and diet/exercise counseling, especially in patients taking glucocorticoids.

He added that “school accommodations are very important in this age group. They might need a plan, for example, to have modified gym class or an excuse not to carry a book bag between classes.”

How did the 13-year-old do? She underwent thymectomy, and her disease remained stable after 6 months. “Her rituximab was discontinued,” Ginsberg said. “She considered participating in a clinical trial but then started seeing improvements. About a year after the thymectomy, she just stopped her steroids on her own, and she was fine.”

Ginsberg had no disclosures.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Inspiring Encounters in the Treatment of Myasthenia Gravis
MDedge Neurology
Myasthenia Gravis: Reflections on Past Challenges and Evolving Strategies
MDedge Neurology
Myasthenia Gravis: 5 Things to Know
MDedge Neurology
Don't Miss the Dx: A 63-Year-Old Man With Proptosis, Diplopia, and Upper-Body Weakness
MDedge Neurology
Placing New Therapies for Myasthenia Gravis in the Treatment Paradigm
MDedge Neurology
Myasthenia Gravis Highlights From AAN 2024
MDedge Neurology
Myasthenia Gravis: Patient Choice, Cultural Change
MDedge Neurology
First-in-Class B-Cell Depleting Agent Promising for Myasthenia Gravis
MDedge Neurology
Sustained Control with Investigational Monoclonal Antibody for Myasthenia Gravis
MDedge Neurology
Myasthenia Gravis: Similar Symptoms in Relatives Raise Question of Genes
MDedge Neurology